Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. In 2019 Synchron was two years into a $10 million series A ...

Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Synchron has raised $200 million to support ...

Synchron Inc. raised $200 million to advance its work building brain implants that doctors can insert through blood vessels, avoiding the costly and high-risk surgeries necessary to install devices ...

New York-based Synchron, a brain-computer interface (BCI) company, has raised $200 million in Series D funding, bringing its total raise to $345 million. Double Point Ventures led the round, with ...

An overview of Synchron's BCI system and how it allows users with motor impairment to control their digital devices. (Image credit: Synchron) Synchron BCI Animation credit: Synchron Funding will ...

Synchron, a brain-computer interface (BCI) company, has released the first public demonstration of an individual using an iPad controlled entirely by thought, leveraging Apple’s built-in accessibility ...

Apple is getting into the brain-computer interface (BCI) business, reveals a press release from New York-based startup Synchron. The idea is to enable people with limited mobility to use iPhones, ...

New York-based Synchron, a brain-computer interface (BCI) company, announced it will be the first BCI company to reach native integration with Apple's new BCI Human Interface Device (BCI HID) profile ...